Pfizer Inc (NYSE:PFE) has declined 0.09 percent to close at $21.05 in today’s session. The share price traded with volume figure of 26.91 million shares as compared to average volume figure of 43.16 million shares per day. The company’s total outstanding common stock accumulates up to 7.69 billion shares out of which 7.68 billion shares are floated in the stock market. Insiders hold a minor proportion of 0.03 percent of its total outstanding common stock while 72.40 percent of outstanding shares are held by large institutions.
The share price seems much stable as its beta stands at 0.70 which shows that the stock price is likely to move by 0.70 times against one point change in market index.
tly the stock price is trading at a relative strength index of 72 depicting that Pfizer is trading at its overbought level and could face correction in future trading sessions. Moving Average Convergence Divergence also indicate a downward trend in the share price as both the MACD and trigger lines are moving in downward direction.
If we compare its price to earnings of 19.33 times with its competitors it’s obvious that Pfizer is a bit overvalued at current price level. GlaxoSmithKline is trading at P/E of 13.68 times while Sanofi Aventis maintains the price to earnings of 13.06 times.
Previous Post » Top Falls at Dow Jones: Alcoa, Du Pont and Hewlett Packard
